Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.
The sinopulmonary tract is the major site of infection in patients with primary antibody deficiency syndromes, and structural lung damage arising from repeated sepsis is a major determinant of morbidity and mortality. Patients with common variable immunodeficiency may, in addition, develop inflammatory lung disease, often associated with multi-system granulomatous disease. This review discusses the presentation and management of lung disease in patients with primary antibody deficiency.
Tarzi
M D
MD
Department of Clinical Immunology, The Royal London Hospital, Whitechapel, UK.
Grigoriadou
S
S
Carr
S B
SB
Kuitert
L M
LM
Longhurst
H J
HJ
D001987:Bronchiectasis / Q000150:complications / Q000628:therapy; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D008171:Lung Diseases / Q000175:diagnosis / Q000628:therapy*; D009894:Opportunistic Infections / Q000150:complications / Q000628:therapy; D011014:Pneumonia / Q000150:complications / Q000628:therapy; D014057:Tomography, X-Ray Computed